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Abstract: Accidental and intended Ricinus communis intoxications in humans and animals 
have been known for centuries but the causative agent remained elusive until 1888 when 
Stillmark attributed the toxicity to the lectin ricin. Ricinus communis is grown worldwide 
on an industrial scale for the production of castor oil. As by-product in castor oil 
production ricin is mass produced above 1 million tons per year. On the basis of its 
availability, toxicity, ease of preparation and the current lack of medical countermeasures, 
ricin has gained attention as potential biological warfare agent. The seeds also contain the 
less toxic, but highly homologous Ricinus communis agglutinin and the alkaloid ricinine, 
and especially the latter can be used to track intoxications. After oil extraction and 
detoxification, the defatted press cake is used as organic fertilizer and as low-value feed. In 
this context there have been sporadic reports from different countries describing animal 
intoxications after uptake of obviously insufficiently detoxified fertilizer. Observations in 
Germany over several years, however, have led us to speculate that the detoxification 
process is not always performed thoroughly and controlled, calling for international 
regulations which clearly state a ricin threshold in fertilizer. In this review we summarize 
knowledge on intended and unintended poisoning with ricin or castor seeds both in humans 
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and animals, with a particular emphasis on intoxications due to improperly detoxified 
castor bean meal and forensic analysis. 
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1. Introduction 
The castor oil plant Ricinus communis, also known as Palma(e) Christi or wonder tree, is a 
perennial scrub of the spurge family Euphorbiaceae (Figure 1a). Ricinus communis probably originates 
from Africa and was used in ancient Egypt and by the Romans and Greeks [1–3]. Nowadays the plant 
grows wild in many tropical and subtropical regions and is found as an ornamental plant virtually all 
around the world. Historically, the plant, the seeds and in particular the oil have been used for a variety 
of medical purposes, for example, as a laxative or for treatment of infection and inflammation [1]. 
Castor seeds are a rich source of oil which can be extracted by milling, boiling, pressing or solvent 
extraction. Apart from medical applications, the oil has long been used as an inexpensive fuel for oil 
lamps. Because of its high proportion of the fatty acid ricinoleic acid, today it is a valued industrial raw 
material for lubricants, paints, coats, cosmetic products and many more [4,5]. Interestingly, in western 
Africa alkaline-fermented castor seeds are part of the flavoring soup condiment ogiri [6,7]. Recently, 
Ricinus communis and other Euphorbiaceae like Jatropha curcas gained interest as non-food oil seed 
trees for biofuel/biodiesel production [8,9]. Today, about 1 Mt of castor beans are harvested annually 
for castor oil production, with India, China and Brazil being major producers [5]. The plant, and in 
particular the seeds after oil extraction, are a rich source of protein and have been used to supplement 
feed, following detoxification, intended for, e.g., sheep, cattle, chicken and fish rations [10–17]. In 
fact, the major application of castor seed residual matter is as fertilizer or organic manure [18–21]. 
Generally, the use of castor bean meal, press cake or other residues of the castor oil production as a 
protein source for feed or fertilizer is limited by the toxicity of the seeds, mainly caused by the highly 
toxic protein ricin and the less toxic alkaloid ricinine. Ricin is a water-soluble protein and is thereby 
not extracted into the castor oil, therefore industrial grade castor oil has been found to be safe [22]. 
Various methods including physical, chemical and biological treatment have been employed to 
detoxify the residues of industrial castor oil production to be used for feeding or other  
purposes [18,19,23–27]. To surmount the problem of toxicity, researchers have attempted to obtain a 
non-toxic castor cultivar, so far with limited success [28–31]. 




Figure 1. Ricinus communis (a) The castor oil plant Ricinus communis with characteristic 
seed pods; (b) Seeds of Ricinus communis varieties showing the diversity of different 
R. communis cultivars. From left to right: R. c. zanzibariensis, R. c. zanzibariensis,  
R. c. green giant, R. c. zanzibariensis, R. c. carmencita, R. c. india, R. c. tanzania. 
 
2. Ricin, a Toxic Lectin from Ricinus communis 
While the toxicity of Ricinus communis has been known for centuries, it was only through the 
seminal work of Kobert’s group at the University of Dorpat (now University of Tartu, Estonia) on 
plant toxalbumins that the toxic principle of Ricinus communis was attributed to a protein termed  
ricin [32,33]. Today we know that ricin is contained within the seeds at a percentage of up to 5% [34]. 
Nearly a century later the toxic principle of ricin was elucidated by Endo and co-workers when they 
identified ricin and other plant toxalbumins as RNA N-glycosidases (EC 3.2.2.22 within the enzyme 
nomenclature of the International Union of Biochemistry and Molecular Biology), also known as 
ribosome-inactivating proteins (RIPs) [35,36]. For biosynthesis of ricin in Ricinus communis, please 
refer to the excellent review by Lord and Spooner in this special issue of Toxins [37]. Ricin,  
a prototype AB toxin, consists of a catalytically active A-chain (RNA N-glycosidase) and a  
sugar-binding B-chain (lectin) linked via a disulfide bond [38]. Cell binding occurs through the  
B-chain and involves different oligosaccharide residues on the cell surface. Several oligosaccharide 
residues, including N-acetylglucosamine and galactose residues on glycolipids and glycoproteins, are 
known receptors for the lectin subunit, and these oligosaccharides show a broad and abundant presence 
on mammalian cells [39–41]. In fact, various oligosaccharides have been used for purification of ricin 
by affinity chromatography [42–45]. The understanding of ricin (RCA60) was complicated by the 
presence of a homologous protein, later identified as Ricinus communis agglutinin (RCA120), a much 
less toxic dimeric protein with high sequence identity to ricin. The co-existence of two highly similar 
proteins, one a potent cytotoxin (RCA60), the other an effective haemagglutinin (RCA120), came to 
light by improved separation methods and by molecular identification of the two different genes [41,46]. 
Later, an isoform of ricin named ricin E (while the original ricin is now termed ricin D) was discovered 
both on protein and on DNA levels to contain a hybrid B-chain of ricin and R. communis agglutinin, 
adding further complexity to the issue [47–49]. Whereas ricin is a monomeric AB toxin of about  
60 kDa formed by a covalently linked A- (~32 kDa) and B-subunit (~34 kDa), R. communis agglutinin 
is a ~120 kDa homodimer of two A- (~32 kDa) and B-subunits (~36 kDa) [50]; in one publication, a 
disulphide bond between the two A-chains of RCA120 has been shown by X-ray crystallography [51]. 




On amino acid levels, both the A- and the B-chains of RCA60 and RCA120 show a high degree of 
homology of 93% and 84%, respectively [46], reflecting similar but not identical structures and 
biochemical properties [52,53]. The corresponding B-chains of RCA60 and RCA120 are not as highly 
conserved as the A-chains, but still bind to identical oligosaccharides like β-1,4-linked galactose 
residues; additionally, ricin shows selective binding to N-acetylglucosamine oligosaccharides [39,41]. 
Both A-chains isolated inhibit ribosome activity in a cell-free system, however, the A-chain of 
RCA120 to a lesser extent (5 to 14-fold; [54,55]). The difference in toxicity between ricin and 
agglutinin is much more pronounced, with ricin being about 100–2000 times more toxic than 
agglutinin, depending on the experimental system used [41,43,53,56]. This might be due to the slightly 
different binding repertoire of the B-chains [39,57] and, additionally, differences in the haemagglutination 
activity of ricin and agglutinin. R. communis agglutinin, on the other hand, shows a much more 
profound haemagglutination activity than ricin [41,43], leading to the speculation that a high 
proportion of agglutinin might bind to serum glycoproteins or erythrocytes and might not be available 
for its toxic action [53].  
The journey of ricin from the cellular surface to the ribosome has been the focus of recent research, 
highlighting common uptake and transport mechanisms also described for other proteins (for review 
see this special issue of Toxins, Lord and Spooner 2011 and [58–61]). Ricin, with its lectin subunit  
(B-chain), binds to oligosaccharide residues on the cell surface and undergoes endocytosis via  
clathrin-dependent and -independent mechanisms that are somewhat dependent on the cell type and 
polarisation status studied [62–67]. Internalized ricin reaches the early endosomal compartment from 
where the majority is recycled or undergoes degradation in the lysosomes, whereas only a minor 
fraction reaches the trans-Golgi network [64,68–73]. Once in the Golgi, ricin is transported 
retrogradely to the endoplasmic reticulum (ER) by yet unexplored pathways [74–78]. Until ricin has 
reached the ER it still consists of a heterodimer of the A- and B-subunit; within the ER it is reduced by 
disulfide isomerase and separates into the two chains [79,80]. In the ER the ricin A-chain subverts the 
so-called ER-associated degradation process, by which misfolded proteins are eliminated, and is 
transported into the cytosol [81–88]. Finally, after retrotranslocation into the cytosol, the A-chain binds 
to the ribosomal stalk of the ribosome [89]. At the ribosome it removes an adenine from the so-called 
sarcin-loop of the 28S rRNA, thereby preventing binding of elongation factors and further protein 
synthesis [89–91]. Apart from this major interruption of cellular function, ricin is also capable of 
inducing apoptosis by yet not fully understood mechanisms [92–97].  
The endogenous function of ricin within the plant remains elusive; based on the cytotoxic activity it 
is speculated that it might function in the defense against all sorts of plant-eating or -damaging 
organisms [98–101]. 
3. Ricin, a Dual-Use Substance 
On the one hand, the ricin-producing plant is of economic interest for the production of castor oil 
and the numerous industrial, medical and cosmetic products derived thereof. The oil contains high 
levels of the unusual fatty acid ricinoleic acid that is valued for its unique chemical properties. 
Furthermore, with respect to medical applications, the ability of the A-subunit to induce cell death has 
been exploited for the development of immunotoxins. Immunotoxins combine the toxic principle of a 




toxin with the exquisite binding specificity of antibodies in one chimeric molecule [102]. Ricin  
A-chain was one of the first examples of a toxin coupled to monoclonal antibodies against cell surface 
proteins and was used experimentally for the treatment of various cancers [103–106]. However, 
unexpected side effects like the so-called vascular leak syndrome hampered the efforts [107–109], but 
progress has been made recently including phase I or III clinical trials, respectively [106,110]. 
On the other hand, ricin has attracted dangerous interest as it has a history of military, criminal and 
terroristic use. The toxin has been explored for potential military use by different nations. It was 
included in different weapons programs during World War II (codename: compound W), and 
weaponised material was later produced until the 1980s [111–114]. Based on its history, ricin is a 
prohibited substance both under the Chemical Weapons Convention (CWC, schedule 1 compound) and 
the Biological Weapons Convention (BWC) and its possession or purification is strictly regulated and 
controlled by the Organization for the Prohibition of Chemical Weapons (OPCW). The relative ease in 
preparing a crude extract and the world-wide availability of the plant has also made ricin a potential 
agent of bioterrorism. It is therefore listed as category B agent of potential bioterrorism risk by the 
Centers for Disease Control and Prevention [115,116]. Ricin has gained notoriety as the most likely 
agent used in the assassination of the Bulgarian dissident Georgi Markov in London in 1978 and the 
attempted murder of Vladimir Kostov in Paris (Table 1; [117]). In the past, the focus fell on the toxin 
for criminal use and various attempted acts of bioterrorism. To provide a few examples, ricin was 
found in threat letters to members of the US Senate and the White House (in 2003/2004);  
Ricinus communis seeds and means for the preparation of ricin have been discovered during a raid 
against terrorists in London in 2002. In a number of cases worldwide, the production and possession of 
ricin has been well documented. These aspects of ricin are reviewed by Griffiths in this special issue  
of Toxins. 
4. Toxicity of Ricin and R. communis Agglutinin 
When assessing the numerous reports on intoxications with ricin, R. communis seeds or  
R. communis-containing feed and fertilizer, some general aspects have to be considered. The term ricin 
in any toxicological publication suggests a degree of homogeneity or a lack of variability that might be 
expected for pure chemicals. Proteins, however, are usually purified and extracted from living sources 
and show a more or less endogenous variability which has to be kept in mind when comparing 
toxicities given in different publications. For R. communis, a large number of different cultivars are 
known, and the high variability of the cultivars can be nicely demonstrated on the plant and also on the 
seeds which are phenotypically quite diverse. As shown in Figure 1b, R. communis zanzibariensis is 
particular among the R. communis cultivars as it comes in different seed shapes and colors, and it can 
also be clearly distinguished from other cultivars based on its biochemical characteristics [118,119]. 
Small and large seeds of different cultivars have been reported to contain different levels of ricin D and 
ricin E, respectively [47,118,120]. As mentioned above, ricin is not the only toxic protein in the seeds, 
it shares a high degree of homology with R. communis agglutinin. Recently, sophisticated sequence 
analysis methods have revealed that ricin and R. communis agglutinin are not single-copy genes. 
Rather they are members of a ricin gene family encoding seven full-length ricin or ricin-like proteins 
and several potential shorter gene products of unknown expression and function, reflecting a much 




greater variability than previously anticipated [121,122]. The full-length proteins of the ricin gene 
family have been shown to inhibit protein synthesis similar to ricin itself [121]. Additional 
heterogeneity of ricin is based on different glycosylation patterns [118], and variable toxicities of ricin 
isoforms have been correlated with different glycosylation levels [123,124]. 
Based on the variability described, it could be retrospectively assumed that the toxicity of ricin has 
mostly been determined with toxin preparations containing a mixture of differently glycosylated ricin 
isoforms (which might or might not contain R. communis agglutinin to a variable degree, especially in 
the older literature when chromatographic separation techniques were not as advanced as today). 
Toxicity data might also depend on the application of different purification protocols, including acid 
precipitation (may influence [re-]folding), elution with sugars (may affect B-chain binding) or salt 
conditions, all resulting not only in different purities but also different functional activities [125]. 
Furthermore, a certain degree of variability in toxicity data is linked to the experimental system used, 
e.g., the animal species or strain used and the cell culture or in vitro assay used [126–128]. Considering 
all these different points, the following numbers are the best estimates to summarize a great deal of 
experimental work done in different laboratories. Ricin acts in a time- and concentration-dependent 
manner [56,125]. Notably, there is a time delay of about 10 h before death occurs even with very high 
doses applied [125]. By intravenous injection of ricin into mice, the dose that produces death in 50% of 
animals (LD50) was found to lie between 2–8 µg/kg body weight [41,125,128–132]. In rats  
0.35–0.5 µg/kg, guinea pigs 0.4–0.5 µg/kg, rabbits 0.03–0.06 µg/kg and dogs 1.65–1.75 µg/kg were 
reported [131]. Somewhat more divergent amounts between 2.4 and 36 µg/kg were needed to produce 
death in 50% of mice after intraperitoneal injection [56,128,132–134]. The inhalational toxicity (in 
estimated LD50) was reported to be between 2.8 and 12.5 µg/kg in different mouse strains [127,135]. 
Using the same application route, the LD50 for two different R. communis cultivars in rats has been 
reported to be between 3.7 µg/kg and 9.8 µg/kg [136–138]. It has to be considered that calculation of 
effective doses in inhalational challenging experiments is more complicated than that for injection, 
since the effective delivery into the deep lungs depends—among other things—on the particle size, the 
solvent used and the technical specifications of the aerosol chamber [135,137,139]. In non-human 
primates the LD50 after inhalational application was found to be 5.8 µg/kg for African green monkeys 
and 15 µg/kg for rhesus monkeys [127]. The least toxic route is oral uptake or intra-gastric delivery 
and is about 1000 times less toxic than parenteral injection or inhalation. For mice 21.5 mg/kg and  
30 mg/kg were reported [132,140,141]. Although different values for oral LD50 in rats are cited in the 
secondary literature, clear data within the accessible primary literature are scarce; the oral LD50 in rats 
was estimated to be up to 20–30 mg/kg ([140,142]; this point is relevant since certain national 
regulations for R. communis-derived products rely on oral LD50 values in rats; see below). With respect 
to humans, the median lethal oral dose for ricin has been estimated to be 1–20 mg/kg of body weight 
on the basis of real cases reporting castor bean poisoning [111]. Data on the in vivo toxicity of purified 
RCA120 indicates that the protein is about 1000 times less toxic than ricin in mice after intraperitoneal 
injection, and an LD50 of ~8 mg/kg was given [41]. Others reported slightly lower LD50 values of  
1.36 and 1.40 mg/kg after intravenous injection [56,134]. 





Apart from the highly toxic ricin and the less toxic R. communis agglutinin the plant contains 
another toxic compound, the low molecular weight alkaloid ricinine (MW = 164.2 g/mol). Ricinine  
or 3-cyano-4-methoxy-N-methyl-2-pyridone (CAS 524-40-3) belongs to the group of piperidine 
alkaloids. It was first discovered and named by Tuson in the seeds of Ricinus communis while 
searching for its medically active compounds even before ricin was known [143]. Subsequently, its 
chemical structure was identified [144–147] and its biosynthesis and metabolism was studied [148,149]. 
Ricinine can be found in all parts of the plant and it is a quite strong insecticide. The castor seeds 
contain approximately 0.2% of the alkaloid. In experimental mouse models ricinine causes 
hyperactivity, seizure and subsequent death due to respiratory arrest. LD50 values for ricinine were  
340 mg/kg for intraperitoneal and 3 g/kg for oral incorporation [150]. Therefore, in comparison to 
ricin, ricinine is significantly less toxic. However, much smaller doses (20 mg/kg) are sufficient to 
induce CNS effects like seizures in mice [151,152]. Unlike ricin, ricinine cannot be inactivated by 
conventional heat treatment because of its high temperature resistance (melting point ~200 °C). 
Therefore, only after elimination of ricinine by solvent extraction is the residue from castor oil 
production suitable for animal feeding. 
In summary, Ricinus communis contains a complex cocktail of toxic substances including the type 
II RIP ricin, the haemagglutinin RCA120 and the alkaloid ricinine. Furthermore, other compounds like 
fatty acids, flavonoids and saponins have been found to exhibit deleterious effects on bacteria, virus, 
fungi, invertebrates and higher animals, seemingly giving the plant some sort of protection in a hostile 
environment [153–157]. Furthermore, allergenic reactions against Ricinus communis, in particular the 
seed dust, were realized [158–160]. Low molecular proteins, 2S albumins, have been identified as the 
main allergenic compounds [161–164]. Experimental intoxication studies underline the major 
contribution of ricin compared to other hazardous compounds found in the seeds [132]. 
6. Ricin Intoxications in Humans 
When reviewing case reports of ricin intoxications in humans, “effective” ricin doses that have been 
incorporated can only be estimated according to variations in the size, weight and moisture content of 
the seeds; cultivar, region, season and period of plant growth at the time of uptake as well as degree of 
mastication, stomach content, age and comorbidities which are obviously more heterogeneous 
compared to experimental poisoning of animals [111]. In clinical reports, the number of seeds ingested 
causing mild to severe symptoms, including a fatal outcome, range from uptake of only single seeds to 
up to 30 seeds [32,33,111]. Overall, the majority of intoxications occur accidentally and are due to 
incorporation of Ricinus communis seeds; only in some cases intended uptake of castor seed extracts 
has been documented in attempting suicide (Table 1). Fatalities after uptake of seeds mainly occurred 
in the pre-modern medicine era without effective supportive care. In those cases of attempted suicide 
where seed extracts were self-injected, the fatality rate seems to be higher (five out of seven injectional 
cases were fatal, Table 1), reflecting the higher toxicity after parenteral application. Human cases until 
1900 are reviewed by Stillmark [33], while Balint, Rauber and Challoner summarize about 700 cases 
until 1990 [165–167]. Examples of more recent cases will be given below. Most often accidental 




poisoning occurs by unaware children who are attracted by the appearance of the seeds [168];  
some cases describe the uptake of seeds by adults out of curiosity or because the seeds are mistaken for 
nuts (Table 1).  
Generally, independent of the uptake route (oral or parenteral injection) the symptoms induced by 
ricin were quite similar, and the severity of symptoms increases with the amount of toxin incorporated. 
Symptoms arose after 3 to 20 h after ingestion or injection. Physical symptoms were abdominal pain, 
emesis, diarrhea with or without blood, muscular pain, cramps in the limbs, circulatory collapse, 
dyspnoea and dehydration. Muscular pain and circulatory collapse were more commonly observed 
with injected ricin, as well as pain at the injection site. Biochemical analyses often revealed increase in 
white blood cells, blood urea nitrogen (BUN), aspartate aminotransferase (AST) and alanine 
aminotransferase (ALT), indicating dysfunction of liver and kidneys. Autopsy in fatal cases showed 
haemorrhagic necrosis in intestines and heart and oedema in lungs. 
A comprehensive review from a Sri Lankan hospital records local child poisoning cases between 
1984 and 2001, reporting 46 cases of accidental Ricinus communis intoxications (and further cases 
caused by intoxication with Abrus precatorius, Jatropha curcas, Manihot utilissima, and others), all of 
them not fatal; all patients experienced vomiting and some dehydration and abdominal pain [169]. 
Other areas where Ricinus communis is endemic or grown on an industrial scale also report a high 
number of accidental intoxications in children. From India, 57 non-fatal cases between 1962 and 1965 
were reported [170]. In 1980 in the USA, a boy ingested up to four Ricinus communis seeds of an 
ornamental necklace. His mother brought him to the emergency clinic where emesis was induced, 
followed by charcoal treatment and cathartics. He was able to leave the hospital 72 h later [171]. The 
publication highlights the danger linked to the ornamental use of decorative, but toxic plant seeds. 
However, also in the last decade, adults including the elderly have been involved in ricin intoxications. 
In Malta, an elderly man was admitted to a clinic with persistent vomiting and watery diarrhea after he 
had eaten 10 seeds, later identified as seeds from Ricinus communis; he was dehydrated, tachycardic 
and hypotensive. Under supportive management (fluids) he fully recovered and left the hospital 7 days 
later [172]. In a case in Australia in 1995 a young adult ingested 10–15 Ricinus communis seeds out of 
curiosity and presented at the emergency department with persistent vomiting and abdominal pain; 
after successful treatment (fluids, charcoal, emetics) he was able to leave the hospital on the third  
day [173]. In a case in Great Britain in 1992, a chemist injected himself with a watery extract of a 
single seed out of curiosity, reportedly not in a suicidal attempt (containing about 150 mg ricin based 
on the analysis of the remaining extract). He developed severe headache and rigors, liver damage and 
pyrexia were observed for 8 days, but he fully recovered after 10 days [174]. 
A very recent review on the American Association of Poison Control Centers reports 45 fatalities 
out of more than 2 million plant poisonings between 1983 and 2009, of these, only one fatal case was 
attributed to Ricinus communis, while the majority (16 deaths) was caused by Datura and Cicuta 
species [175]. A review by the Swiss Toxicology Information Centre mentioned 130 serious cases 
including five fatal plant poisonings between 1966 and 1994, among them three non-fatal cases related 
to Ricinus communis [176]. These reviews of local plant poisonings support the opinion that 
intoxications with Ricinus communis usually do not belong to the most common or serious poisonings 
occurring accidentally in humans. 




The seeds of Ricinus communis have a long history as medical remedy; it is therefore not surprising 
to find cases linked with adverse reaction to them: A Korean woman who had eaten five castor seeds 
in order to treat constipation was admitted to hospital with severe nausea, vomiting, abdominal pain 
and initially near hypothermia; in this case ricin was detected in urine samples, symptoms were treated 
(fluids, charcoal) and she was discharged after 2 days [177]. Similar cases have been reported from 
Brazil and Croatia [178,179]. In Japan a man bought Ricinus communis seeds to treat his rheumatic 
condition. Not realizing the seeds were meant to be used for dermal application in an ointment he 
swallowed about 30 of them; the next day he presented at a hospital with diarrhoea, vomiting and 
abdominal pain. Gastric lavage was performed and fluids and charcoal were given. Even in this severe 
case the patient recovered and could leave the hospital 8 days later [180]. A report from Oman 
describes the case of a man who ate one green seed of Ricinus communis as a traditional treatment 
against coughing. After vomiting he presented at the local hospital in a confused and disoriented, 
afebrile state with sluggish pupil reflex, mydriasis and high pulse rate. He was treated symptomatically 
and with charcoal, within two days he returned to normal [181]. A unique case occurred in 2009 in the 
USA: an unlicensed practitioner illicitly injected 500 mL of castor oil into a person for hip 
augmentation, the oil was intended to be used as silicone substitute [182]. The patient immediately 
developed severe symptoms including fever, tachycardia, haemolysis, thrombocytopenia, hepatitis, 
respiratory distress and anuric renal failure. After intensive supportive care (mechanical ventilation and 
haemodialysis), the patient was discharged 11 days later, requiring dialysis for an additional  
1.5 months. In this unique case, ricinine was detected in the patient’s urine. The case also showed that 
ricinine can be found as a biomarker in refined “medicinal” castor oil preparations. The lack of CNS 
symptoms and seizures led to the assumption that the patient’s toxicity could be attributed to castor oil 
and ricinoleic acid [182]. 
In cases of intended uptake of ricin different reports describe suicides by injection of a self-made 
seed extract in Poland, Belgium and the US (Table 1). A fatal suicide took place in Poland, here a man 
subcutaneously injected himself with a Ricinus communis seed extract and was admitted 36 h later to 
the clinic with nausea, dizziness, pain and severe weakness. He deteriorated with haemorrhagic 
diathesis and multi-organ failure and died after asystolic arrest 18 h later [183]. The second case 
regards a chemist, who injected himself intravenously with a solution of acetone and crushed seeds. 
Asymptomatic at presentation at the emergency clinic, he quickly developed vomiting, bloody 
diarrhoea, hypotension and lost consciousness. He died during intensive care within 12 h [184].  
In Belgium, a man poisoned himself by injecting (i.v. and i.m.) about 10 mL of a self-made  
acetone-extract of Ricinus communis seeds. Twenty-four hours post injection he presented at the 
hospital with vomiting, diarrhoea, nausea, vertigo, pain and severe dehydration, despite immediate 
intensive care he died after 9 h. Ricinine and acetone were detected in urine, blood and vitreous humor, 
while detection of ricin was technically not feasible [185]. Also in Belgium, a man had prepared an 
extract of the seeds and injected the extract to his wife and himself. Both presented at the emergency 
clinic 12 h later with fever. Treatment with tetanus vaccination, immune globulins, systemic 
antibiotics, corticosteroids and local wound care was initiated but both developed necrotising fasciitis. 
Despite extensive debridement or amputation their conditions worsened and finally resulted in death. 
Ricin was found in the content of the syringe and in the urine [186]. As mentioned above, compared to 
oral uptake, injections of R. communis seed extracts typically result in a much more severe clinical 




course but must not necessarily be fatal as a case from France illustrates. In a suicide attempt, a man 
with depression chewed and masticated 13 seeds and injected the product into his thigh. Necrotic 
tissue was excised by emergency surgery and antibiotics were given, but three further operations were 
necessary to remove necrotising tissue before the patient’s condition improved so that he could be 
discharged after 3 months [187]. 
Overall—among all plant poisonings reported—human cases of ricin poisoning are rare. With 
modern supportive care the fatality rate is low, except in suicide cases where a ricin-containing extract 
is injected, reflecting the higher toxicity after parenteral application. 
Figure 2. Summary of human and veterinary intoxications with ricin as displayed in detail 
in Table 1 and Table 2. (a) Human intoxications with ricin as displayed in detail in  
Table 1. Human cases are presented either as accidental or intended intoxications and are 
further sub-divided into oral and injectional intoxications. The number of cases reported 
and the number of fatal cases among them are given within the table (left) and as pie chart 
(right) with number of oral cases (blue), injectional cases (green) and the number of fatal 
cases highlighted (hatched); (b) For veterinary intoxications with ricin, details on cases 
occurring in dogs are summarized as shown in detail in Table 2. The table (left) and the 
corresponding pie chart (right) show the number of dogs poisoned accidentally in Germany 
(pale blue) and world-wide (blue) and the number of fatal cases (hatched). Cases 
mentioned by Milewski et al. were not considered because of lack of information on the 
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Table 1. Summary of human intoxications with ricin. 
Human Cases: Accidental 
 Uptake/Ingestion Outcome Where Detection and Diagnosis 1 Ref. 2 
101 people (different age) ingestion and injection of varying amounts of Ricinus communis derivates 6 fatal worldwide circumstantial evidence [33] 
man (age 26) in 1900 ingestion of unknown amount of castor seeds recovered UK circumstantial evidence [189] 
juvenile (age 15) in 1902 ingestion of 10 or 12 castor seeds fatal USA circumstantial evidence [190] 
4 adults (age unknown) in 1903 ingestion of 1, 4, 6 and 14 castor seeds, respectively recovered Cuba circumstantial evidence [190] 
man (age 50) in 1903 ingestion of 2 castor seeds recovered UK circumstantial evidence [191] 
man (age unknown) in 1920 ingestion of 5 castor seeds fatal USA circumstantial evidence [192] 
2 women (age 22 and 41) ingestion of 2.5–5 castor seeds for treatment of stomach convulsions fatal Hungary circumstantial evidence [193] 
man (age unknown) drinking of an extract made of a fistful castor seeds fatal Hungary circumstantial evidence [193] 
man (age 24) in 1934 ingestion of 15–20 castor seeds fatal Germany circumstantial evidence [194] 
4 adults (age unknown) ingestion of 1–15 castor seeds recovered Austria circumstantial evidence [195] 
child (age 7) in 1941 ingestion of 4 castor seeds recovered Italy circumstantial evidence [196] 
woman (age 60) in 1948 ingestion of 10 castor seeds for relaxant recovered Brazil circumstantial evidence [178] 
2 people (age unknown) in 1950–1952 ingestion of unknown amount of castor seeds recovered Italy suspected [197] 
10 children (age 11–13) in 1958 ingestion of 0.5–6 castor seeds recovered Hungary circumstantial evidence [198] 
man (age 42) ingestion of 10 seeds recovered Poland circumstantial evidence [199] 
57 children (age 1–5, >5) in 1962–1965 ingestion of unknown amount of castor seeds, on average 4–5 recovered India circumstantial evidence [170] 
443 children (age <19) in 1964–1969 ingestion of unknown amount of castor seeds recovered USA suspected [200] 
man (age 57) 
in 1970 ingestion of unknown amount of castor seeds, which were thought to be 
scarlet runner beans 
recovered Netherlands circumstantial evidence [201] 
4 men (age 7–18) ingestion of 1–2 castor seeds recovered India circumstantial evidence [202] 
family of 4 people (age 8–44) in 1974 ingestion of 2–10 castor seeds recovered Italy circumstantial evidence [203] 
girl (age 17) in 1965 ingestion of 1 castor seed recovered UK circumstantial evidence [204] 
child (age unknown) In the 1970s ingestion of unknown amount of castor seeds recovered India circumstantial evidence [205] 
boy (age 4) in 1979 ingestion of 4 castor seeds from an ornamental necklace recovered USA circumstantial evidence [171] 
girl (age 2) in 1979 ingestion of at least 1 castor seed recovered USA circumstantial evidence [171] 
7 children (age unknown) in 1968–1970 ingestion of 1–10 castor seeds because of good taste recovered Croatia circumstantial evidence [179] 
7 adults (age unknown) in 1968–1970 ingestion of 1–10 castor seeds as laxative recovered Croatia circumstantial evidence [179] 




Table 1. Cont. 
Human Cases: Accidental 
 Uptake/Ingestion Outcome Where Detection and Diagnosis 1 Ref. 2 
2 children (ages 4 and 5) 
in 1979 ingestion of unknown amount of castor seeds which were found in a 
canister together with walnuts 
recovered USA circumstantial evidence [206] 
4 adults (age 19–21) ingestion of 0.5–1 castor seed recovered Denmark circumstantial evidence [207] 
10 children (age 6–8) ingestion of 1–7 castor seeds and just contact, respectively recovered Spain circumstantial evidence [208] 
2 boys (age 17) ingestion of 8 and 3 castor seeds recovered Israel circumstantial evidence [209] 
9 children (age 7 to 12) in 1984 ingestion of 1–2 castor seeds which were taken to school recovered USA circumstantial evidence [165] 
child (age 11) ingestion of 1 castor seed during lesson in school recovered UK circumstantial evidence [210] 
man (age 21) ingestion of 12 castor seeds, which were thought to be hazelnuts recovered USA circumstantial evidence [211] 
woman (age 80) ingestion of unknown amount of shelled castor seeds out of ambiguous reasons recovered USA circumstantial evidence [211] 
woman (age 52) ingestion of 10–15 castor seeds without knowledge of its toxicity recovered Spain circumstantial evidence [212] 
child (age 3) ingestion of two or more castor seeds recovered USA suspected [166] 
man (age 28) ingestion of 4 castor seeds as treatment against constipation recovered USA circumstantial evidence [166] 
man (age 39) ingestion of 4 castor seeds, man declared, that he often eats roasted castor seeds recovered USA circumstantial evidence [166] 
28 children (age < 15) in 1986 ingestion of unknown amount of castor seeds recovered Sri Lanka suspected [213] 
man (age 36) extract of 1 castor seed was injected, against migraine or out of curiosity recovered UK circumstantial evidence [174] 
3 patients (age unknown) in 1966–1994 ingestion of unknown amount of castor seeds recovered Switzerland circumstantial evidence [176] 
young adult (age unknown) in 1995 ingestion of 10–15 castor seeds out of curiosity recovered Australia circumstantial evidence [173] 
girl (age 20 months) ingestion of 2 or more castor seeds recovered Canada circumstantial evidence [214] 
5 people (age unknown) ingestion of unknown amount of castor seeds recovered Tunisia not described [215] 
man (age 70) ingestion of 10 castor seeds recovered Malta circumstantial evidence [172] 
120 people (different age) in 1955 ingestion of varying amounts of castor seeds 1 fatal Europe circumstantial evidence [216] 
child (age 3) ingestion of 5–6 castor seeds recovered Germany circumstantial evidence [216] 
man (age 69) 
swallowing of 30 seeds without chewing; intended use: medical treatment of 
rheumatism, external application was recommended 
recovered Japan circumstantial evidence [180] 
46 children (age unknown) in 1984–2001 ingestion of unknown amount of castor seeds recovered Sri Lanka suspected [169] 
man (age 51) ingestion of one green fruit of castor plant as treatment against cough recovered Oman circumstantial evidence [181] 
woman (age unknown) injection of 500 mL castor oil for hip augmentation by unlicensed practitioner recovered USA detection of ricinine in urine [182] 
woman (age 56) ingestion of 5 wild castor seeds as treatment against constipation recovered Korea detection of ricin in urine [177] 




Table 1. Cont. 
Human Cases: Intended 
 Uptake/Ingestion Outcome Where Detection and Diagnosis 1 Ref. 2 
Georgi Markov (age 49) 
in 1978 assassination of Markov: poking with an umbrella for injection of a pellet 
with channels probably containing ricin 
fatal UK suspected 
[117, 204, 206, 
217, 218] 
Vladimir Kostov 
in 1978 attempted assassination of Kostov: shot in his back with an air pistol for 
injection of a pellet with channels probably containing ricin 
recovered France suspected [117] 
man (age 21) ingestion of 30 castor seeds in attempting suicide, only some were masticated recovered France detection of ricin in plasma and urine [219] 
woman (age 38) in 1985 ingestion of 24 chopped castor seeds in attempting suicide recovered USA circumstantial evidence [165] 
woman (age 20) ingestion of 12 castor seeds in attempting suicide recovered Spain circumstantial evidence [220] 
adolescent (age 16) ingestion of 2 castor seeds in attempting suicide recovered USA circumstantial evidence [221] 
man (age 20) subcutaneous suicidal injection of castor seed extract fatal Poland suspected [183] 
man (age 53) 
chewing of 13 castor seeds. The mastication product was injected in attempting 
suicide 
recovered France circumstantial evidence [187] 
man (age 61) intention: suicide, injection of a solution of crushed castor seeds fatal USA detection of ricinine in urine [184, 222] 
man (age 56), woman (age 59) injection of extracted ricin from castor seeds into his wife and himself fatal Belgium detection of ricin in urine and syringe [186] 
man (age 49) i.v. and s.c. injection of castor seed extract in attempting suicide fatal Belgium 
detection of ricinine in blood, urine, 
and syringe 
[185] 
1 Circumstantial evidence: the causative link to ricin intoxication is based on details of the case report, e.g., known or observed uptake of plant seeds, finding of plant material etc.; suspected: suspicion of ricin 
intoxication based on symptoms observed. 2 Table is organized by the publication date of literature cited. The table focuses on case reports including clinical signs, symptoms and treatment and makes no claim to  
be complete. 
Table 2. Summary of animal intoxications with ricin. 
Animal cases: dogs 
 Uptake/Ingestion Outcome Where Detection and Diagnosis 1 Ref. 2 
5 dogs in 1977–1979 ingestion of organic fertilizer 3 fatal Germany circumstantial evidence [223] 
98 dogs in 1989–2000 ingestion of unknown amount of castor seeds 7 fatal USA suspected [224] 
19 dogs in 2001 ingestion of fertilizer containing castor seeds 7 fatal Germany 
circumstantial evidence; detection of ricin 
in fertilizer 
[225] 
dog in 2002 ingestion of castor seed cakes used as fertilizer fatal Brazil circumstantial evidence [226] 




Table 2. Cont.  
Animal Cases: Dogs 
 Uptake/Ingestion Outcome Where Detection and Diagnosis 1 Ref. 2 
dog in 1999 ingestion of fertilizer based on castor seeds recovered Brazil circumstantial evidence [227] 
dog in 1999 ingestion of motor oil based on castor oil recovered Brazil circumstantial evidence [227] 
35 dogs in 2001–2003; details of  intoxication not described not described USA suspected [188] 
puppy ingestion of unknown amount of castor beans fatal USA detection of ricinine in stomach content [228] 
dog ingestion of unknown amount of castor beans recovered Germany circumstantial evidence [229] 
2 dogs ingestion of fertilizer composed of R. communis material fatal  Belgium 
detection of ricinine in gastric and intestinal content , liver  and 
kidney 
[230] 
15 dogs in 2007 ingestion of soil conditioner with 10 % oil cake 13 fatal  Korea suspected [231] 
9 dogs in 2010, ingestion of fertilizer containing R. communis 2 fatal Germany detection of ricinine in urine and ricin in fertilizer  and soil this paper 
Animal Cases: Diverse 




in 1873 ingestion of flaxseed flour contaminated with  
castor seeds 
recovered Germany circumstantial evidence [232] 
35 horses 
in 1888 ingestion of flaxseed flour contaminated with  
castor seeds 
1 fatal Germany circumstantial evidence [233] 
70 different 
animals 
in 1950 ingestion of layers’ mash containing castor seed 
husks in meal 
fatal 2 pigs, 1 heifer, 
2 cattle 
Ireland circumstantial evidence [234] 
several 1000 ducks in 1969–1971 ingestion of unknown amount of castor seeds 
fatal for at least 10 
ducks 
USA circumstantial evidence [235] 
1 horse 
in 1999 ingestion and aspiration of ~2 L filtrate made of 
crushed castor seeds mixed with water 
fatal Brazil suspected [236] 
45 sheep and goats  in 2005 ingestion of garden waste containing castor beans  fatal for 15 animals  Iran circumstantial evidence [237] 
1 Circumstantial evidence: the causative link to ricin intoxication is based on details of the case report, e.g., known or observed uptake of plant seeds, finding of plant material etc.; suspected: suspicion of ricin 
intoxication based on symptoms observed. 2 Table is organized by the publication date of literature cited. The table focuses on case reports including clinical signs, symptoms and treatment and makes no claim to  
be complete. 
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7. Ricin Intoxications in Animals 
Based on experimental poisoning of animals with Ricinus communis seeds, a variability in toxicity 
was observed. Whereas horses seem to be most sensitive, followed by geese, rodents and ruminants, 
chicken seem to be the most resistant animals [167,238]. Animals showed similar symptoms as 
humans after intoxication with ricin, that is weakness, profuse watery diarrhoea, dehydration with 
sunken eyes, dilation of pupils, depression, tachycardia, dyspnoea and colics. These signs and 
symptoms developed most frequently within 6–24 h. In biochemical examinations a high packed cell 
volume as a sign of severe dehydration and, as in humans, high activity of serum creatine kinase (CK) 
and AST as well as high concentrations of serum BUN and creatinine have been observed. Pathology 
of deceased animals also revealed gastroenteritis, necrosis and haemorrhage in heart and kidney [237]. 
In dogs, the most common clinical signs and symptoms included vomiting (80%), diarrhoea (37%), 
bloody diarrhoea (24%) and abdominal pain (14%). Biochemical parameters are similar to those in 
other animals [224]. 
While human cases of ricin poisoning mostly occur after ingestion of the unprocessed seeds, animal 
cases have also been described after uptake of processed castor seed products. After oil extraction, the 
press cake of the seeds is a rich source of protein, and is—after detoxification—used as cheap additive 
in organic fertilizer, soil conditioner or animal feed [11,13,21]. However, case reports from Europe, 
America and Asia describe poisoning of domestic animals, especially dogs, after ingestion of organic 
fertilizer containing castor cake (Table 2), leading to the hypothesis that the detoxification process 
itself is problematic and might leave residual active ricin within the press cake. In the majority of cases 
the amount of active ricin left after detoxification has not been quantified. 
Considering the situation in Germany, dog poisoning in conjunction with organic fertilizer 
containing R. communis has been a problem over the last three decades. Since 1980, several 
independent cases have been described [223,225,229], and in our opinion there are a number of 
unreported cases which might not have been recognized. From 1980 until now, we found case reports 
on 34 poisoned dogs including 12 fatal cases in Germany (35%). In this context in 2001 all organic 
fertilizer-containing castor cake was temporarily taken off the German market, but was later  
re-introduced [225]. It is supposed that the fertilizer might be attractive for dogs due to admixing of 
castor cake with different organic additives [223]. 
Exemplarily we briefly describe a recent case that occurred in Dormagen, Germany, in 2010: 9 dogs 
fell ill after ingestion of unknown amounts of organic fertilizer freshly distributed on a local field 
(Figure 3a,b). The dogs were suffering from vomiting, abdominal pain and haemorrhagic diarrhoea, 
and one dog died and another dog was euthanized about 48 h after ingestion. One animal was 
submitted for necropsy. Macroscopically, the stomach showed marked oedema (Figure 3c), and within 
the dog’s small intestine an acute fibrino-haemorrhagic enteritis was identified (Figure 3d). Laboratory 
analysis revealed 1715 µg/g ricin in the fertilizer and 380 and 820 µg/g ricin in two soil  
samples taken from the manured field using a ricin-specific ELISA detecting the active toxin  
(Pauly et al., manuscript in preparation). For comparison, in the case described by Ebbecke et al. in 
2001 up to 10 µg/g active ricin was detected in fertilizer samples [225]. 




Figure 3. Postmortem analysis of a dog deceased after uptake of R. communis-containing 
fertilizer. (a) Sample of organic fertilizer which caused nine cases of ricin intoxication in 
dogs in Germany in March 2010; (b) Soil sample taken from a field which was treated with 
the fertilizer from (a). Both the fertilizer and the soil sample were shown to contain active 
ricin; (c) Stomach of the deceased dog showing marked oedema and hyperaemia; (d) Small 
intestine with acute fibrino-haemorrhagic enteritis; (e) LC-MS/MS spectrum of the dog’s 
urine containing ricinine. The chemical formula of ricinine is given in the inset (molecular 
weight 164.2 g/mol); the peak at m/z = 165 represents the protonated precursor  
ion ([M+H]+). 
 
Based on these results, one of the dogs was thoroughly analyzed for traces of ricin and ricinine in 
different organs and urine. While it was technically not possible to detect ricin or ricin DNA in 
samples taken from kidney, liver, stomach and blood, ricinine was unambiguously detected in the urine 
of the deceased animal using LC-MS/MS techniques and multiple reaction monitoring (Figure 3e). To 




our knowledge, this was the first German case showing a causative link between the ingestion of  
ricin-contaminated fertilizer and a fatal outcome of the poisoning, with ricinine being detected in the 
dog’s urine as a surrogate marker for uptake of R. communis-material. Fatal cases in dogs after 
ingestion of fertilizer or soil conditioner have been reported before from USA, Brazil, Korea and 
Belgium (Table 2; [188,226,230,231]). In most of the cases, the link to R. communis was suspected 
based on the clinical symptoms or on circumstantial evidence, e.g., observed uptake of plant seeds 
(Table 2). However, in the case of dog poisoning in Belgium, ricinine as surrogate marker was 
successfully detected in liver, kidney and gastric and intestinal content [230]. Similarly, Mouser et al. 
detected ricinine in the stomach content of a dog which had ingested an unknown amount of castor 
beans [228]. 
Animal intoxications did also occur in the past due to incorrectly processed feed containing 
R. communis material. In former times, intoxications of farm animals (horses, ruminants) were 
reported after uptake of flaxseed flour contaminated with castor seeds [232,233]. More recently, in 
Iran, sheep and goats were poisoned after ingestion of garden waste containing castor seeds [237]. 
However, nowadays accidental poisoning of animals due to castor plant-contaminated feed is rare, 
most likely because of different national and international regulations which limit the amount of  
R. communis in animal feed. As an example, within the European Union the Commission Directive 
2009/141/EC states R. communis as an undesirable substance in animal feed, with a maximum content 
of 10 mg/kg seeds and husks from the plant allowed relative to animal feed with a moisture content of 
12% [239]. 
In contrast to the existing regulations on animal feed, to our knowledge there is no international 
regulation limiting the amount of R. communis in fertilizer. However, there are national regulations, 
e.g., in Germany the so-called fertilizer regulation which allows R. communis-residual material in 
fertilizer if no acute oral toxicity in rats is observed after uptake of 2000 mg material per kg body 
weight (Düngemittelverordnung -DüMV-, Attachment 2, Nr. 7.1.5; [240]). Currently this regulation is 
under evaluation, based on the recent cases of dog poisoning described. In this context we 
independently tested several samples of organic fertilizer from different brands and found significant 
concentrations of active ricin (up to 3000 µg/g fertilizer), corroborating the hypothesis that the 
detoxification process of castor cake is not always thoroughly performed and controlled. Therefore, it 
is planned to update the German fertilizer regulation to state a definite amount of ricin maximally 
allowed in fertilizer. Since the problem is not restricted to Germany or Europe, international 
regulations should be established to agree on a limit of ricin maximally allowed in fertilizer. To our 
understanding, this limit should not be based on animal oral toxicities (because of ethical concerns in 
animal testing and the variable toxicity in animals), but on the detectable amount of active ricin  
per kg fertilizer. 
In summary, veterinary cases of ricin poisoning occurred in different animal species, mostly in 
domestic animals. Intoxications of animals were caused either by the unprocessed plant seeds or by 
processed castor cake as it is used as by-product in organic fertilizer, calling for international 
regulations which clearly limit the amount of ricin in fertilizer. In contrast to humans, poisoning of 
animals is statistically less well surveyed. Nevertheless, fatality rates have been estimated: from 98 
cases of dog poisoning, Albretsen et al. deduced a fatality rate of about 7% [224]. Based on all cases of 
dog poisoning listed in Table 2 we found a higher fatality rate of 35.3% for Germany and 23.5% 




world-wide (Figure 2B). In humans, however, Rauber et al. reported a fatality rate of 1.8% for  
751 cases observed [165]. Based on all human accidental intoxications listed in Table 1, we found a 
similar fatality rate of 1.5% (Figure 2A). However, among the limited number of intended human 
poisonings reported (Table 1), the observed fatality rate was much higher (45.5%). Therefore, the 
parenteral uptake of ricin leads to a more severe outcome than the oral uptake, as has been expected 
from animal experiments. Furthermore, when comparing fatality rates in human and veterinary cases, 
one might be tempted to speculate that ricin has an increased toxicity in dogs compared to humans 
(Figure 2). However, sound toxicity data for humans and dogs do not exist and additional factors might 
play a role, like adequate and timely treatment of animals or higher accessibility of the toxin from the 
crushed fertilizer material. 
8. Detection of Ricin or Ricinus communis 
In “naturally” occurring cases, the primary diagnosis is based on the case history reported and on 
clinical symptoms. Since ricin induces unspecific symptoms also observed with many other diseases, 
the diagnosis might be difficult as long as the suspicious matter is not identified, e.g., seeds found in 
vomit, intestine or faeces. In any case, laboratory detection is a necessary tool to confirm intoxication 
with R. communis in clinical samples and to screen for the source of intoxication in environmental 
samples (e.g., fertilizer, soil) or food samples. 
Among the different detection methods available, antibody-based immunoassays belong to the 
standard technologies applied to detect and to quantify ricin in clinical and environmental samples as 
well as in food and feed. Enzyme-linked immunosorbent assays (ELISA) have been developed by 
different groups [132,135,241–252]. Some of them are able to quantify ricin with detection limits down 
to a few pg/mL (limit of detection: 2 pg/mL [246] and 40 pg/mL [253]). ELISA-based methods have 
been successfully used to track ricin in tissues after experimental intoxication [132,135,142,244,245,251]. 
Traditional chromogenic substrates have been replaced by electro chemi luminescence [248,253], 
electrochemical [249] or PCR read-out [132,254–256] in order to increase sensitivity and to  
reduce background signal noise, with the most sensitive detection limit of 10 fg/mL given for an 
immuno-PCR approach [254]. Immuno-PCR detection of ricin was used to measure ricin out of food 
matrices and to follow the fate of ricin after experimental intoxication [132,254]. Most ELISA require 
several hours to perform, meaning that valuable time is lost before countermeasures can be 
implemented—this is especially important in case of intentional or criminal use of ricin in a potential 
bioterrorism scenario. This issue was addressed by the development of faster (<1 h) assays based on 
fiber-optic sensors or rapid electrical detection [249,257]. Furthermore, immunochromatographic and 
lateral-flow assays (LFA) have been developed to meet the demand for fast and technically easy  
on-site detection [248,258]. LFA are usually around 1,000 times less sensitive than standard ELISA 
and reach detection limits of 1–50 ng/mL [119,253,259,260]. 
Apart from antibodies, DNA- or RNA-aptamers have been reported to selectively bind  
ricin [261–268]. It has been proposed that they could be used as an alternative to antibody-based 
detection methods [269], but still their diagnostic value in protein detection, especially out of complex 
matrices, is limited. To our knowledge, only one assay based on aptamer technology for detection of 




ricin (B-chain) out of beverages has been published, and a detection limit of 25 ng/mL for intact ricin 
was reported [268]. 
One drawback of all antibody- and aptamer-based assays is that they do not unambiguously detect 
their target molecule, meaning that cross-reactivity to related antigens or high concentrations of 
interfering substances might lead to false positive results. Furthermore, the discrimination of different 
ricin isoforms and/or R. communis agglutinin is technically not feasible. For unambiguous detection of 
ricin and its selective discrimination from R. communis agglutinin, sequence information is necessary. 
Modern state-of-the-art mass spectrometry technologies are able to deliver information on the target’s 
protein sequence and its glycosylation pattern: highly sophisticated technologies like electrospray 
ionisation (ESI) or matrix-assisted laser-desorption/ionisation time-of-flight (MALDI-TOF) mass 
spectrometry (MS) as well as liquid chromatography (LC)-MS/MS analysis of the tryptic peptide 
fragments have been developed to unequivocally identify ricin out of crude toxin preparations [270–274] 
and to analyze its glycosylation pattern [118,124]. However, limited sensitivity and the difficulty to 
identify ricin out of complex matrices lead to the combination of immunoaffinity enrichment with  
MS-based detection. This combination has been successfully applied to the detection of ricin out of 
different complex matrices [115,275–279], yielding a detection limit of down to 0.64 ng/mL [278]. 
While the above-mentioned technologies are very useful to detect the presence of ricin, they lack 
the ability to measure the functional activity of the toxin, i.e., the ability to discriminate inactive  
(non-hazardous) versus active (hazardous) material. This point is important in the case of an 
intentional release of ricin, especially with regard to emergency operating schedules, forensic analysis 
and therapy. The discrepancy between presence of the ricin protein and lack of toxicity has been noted 
for some immunoassays [280], while in other assays detection seems to correlate with  
activity [281–283]. Functional assays for ricin have traditionally been done by animal toxicity tests and 
in vitro cytotoxicity assays [130,284]. Later, cytotoxicity assays have been amended to detect ricin out 
of complex matrices [282,283,285,286]. Using functionally blocking antibodies, these tests enable the 
discrimination of ricin from other cytotoxins. The ability of ricin to inactivate ribosome activity was 
elucidated in the 1970s [287,288], leading to the first functional cell-free in vitro assay [55,289] which 
is in principle still in use for ricin and other RIPs [290,291]. After the molecular mechanism of 
depurination was deciphered [35,36], a number of methods assaying the functional activity of the  
A-chain were developed. The single adenine released by the A-chain was detected by different 
methods including HPLC, MS, fluorescence, RT-PCR or enzymatic reaction [121,292–297]. Since 
adenine might be present in biological samples or be released by unspecific enzymes or other RIPs,  
it was found to be superior first to separate ricin from the matrix by an immunocapture step,  
followed by mass-spectrometric detection of either the released adenine or the depurinated  
substrate [115,277,278,298]. These sophisticated MS-based functional assays have been shown to 
detect ricin from environmental or clinical matrices. These methods combine the measurement of 
functional activity with the discriminatory power of MS for the identification of ricin, resulting in  
a very powerful technology for the detection and functional characterization of ricin out of  
complex matrices. 
While different ricin detection methods were successfully applied to detect ricin in complex 
matrices (also environmental and food matrices involved in real cases), the detection of the toxin itself 
in clinical samples has been difficult in real cases. As shown in Tables 1 and 2, only in three reports 




has ricin been detected in urine or plasma of patients [177,186,219]. The problem with ricin detection 
in forensic analysis is that the molecule is obviously rapidly absorbed within the tissue and internalized 
into the cells, limiting the time window of detection as shown by research in animals. Deduced from 
experimental intoxication of animals, orally applied ricin passes through stomach and small intestine 
within 24 h. Most of the ricin has reached the large intestine by 12 h where it can be detected by 
immunoassays for up to 72 h [299]. From 24 h onwards substantial amounts are found within feces. Up 
to 50% of the applied ricin seems to be absorbed or no longer be available for detection [299]. In a 
similar study, orally administered ricin could soon be detected in faeces (2–24 h), but some ricin 
reaches the blood from which it is quickly absorbed by different tissues [132]. The liver and spleen 
seem to be the most prominent targets, but the total amount of detectable ricin is very small compared 
to the amount applied [142]. In light of the available data it seems reasonable to suggest that the 
majority of orally ingested ricin is destroyed in the stomach and a fair amount is shed with the faeces. 
Only a small proportion seems to reach the bloodstream and the inner organs. In the liver,  
phagocytotic Kupffer cells and sinusoidal endothelial cells have been reported to be the main  
targets [300–304]. Indeed, hepatic Kupffer and sinusoidal endothelial cells as well as other 
phagocytotic cells (e.g., macrophages, granulocytes, dendritic cells) constitute the forefront in 
immunological defense and do not only express glycolipids and glycoproteins on their cell surface, but 
are also equipped with lectin receptors which enable the rapid uptake of ricin into the cells [305,306]. 
As the detection of ricin in real cases is difficult, ricinine has successfully been used as surrogate 
marker in six human and veterinary cases reported so far (Tables 1 and 2). The advantage of ricinine 
biomonitoring stems from the small size of the molecule which can be easily extracted and monitored 
by chromatographic and MS-based methods. Animal studies have shown that ricinine can be detected 
in urine for up to 48 h after exposure in rats [222]. 
Initially, ricinine was detected using paper chromatography, UV detection [307,308] and later liquid 
chromatography (LC) [309] or combinations of LC or gas chromatography (GC) with MS. The latter 
gave superior results and allowed to identify ricinine in crude ricin preparations [310]. Solvent- or 
solid-phase extraction were applied to extract ricinine from food, feed or clinical samples [185,228,311]. 
By using an isotope-labeled ricinine as an internal standard, quantification of the molecule became 
possible [222,312]. The molecule is co-extracted with ricin from the seeds and can be easily detected 
in crude extracts of R. communis. Therefore, oral intoxications with Ricinus communis seeds have been 
successfully confirmed by the detection of ricinine from urine, blood, liver, kidney or gastric content in 
human and veterinary cases [182,185,222,228,230]. 
9. Treatment and Vaccination 
Currently, no approved specific therapy or antidote against ricin intoxication is available. The 
treatment focuses on supportive medicine and involves application of intravenous fluids and 
suppression of hypertension. To prevent further absorption of the toxin, treatment with activated charcoal 
or gastric lavage have been used depending on the time of admission after oral ingestion [111]. 
Several tracks have been followed to identify therapeutic molecules against ricin intoxication, like 
antibodies, small molecule inhibitors, aptamers and sugars [313,314]. So far, antibodies are the only 
class of molecules showing real promise [128,315,316]. Basically, the concept goes back to the 




seminal work of Paul Ehrlich who showed in his work on anti-toxins that animals can be immunized 
against ricin intoxication and that blood from these animals can transfer protection to other  
animals [317]. The fruitful cooperation with Emil von Behring, Shibasaburo Kitasato and Robert Koch 
laid the foundation for the serum therapy and vaccination. Throughout recent years, ricin-specific 
antisera or polyclonal antibodies (pAb) have been generated in different species (e.g., rabbit,  
goat, sheep, chicken and even humans) and tested as post-exposure therapeutic in animal  
models [128,137,318–324]. For ricin it seems that protection can be conferred by antibodies when 
given concurrently or within 10 h after intoxication, depending on the route of toxin uptake [128,132]. 
Once ricin has been internalized into the cells, it cannot be inactivated by antibodies, limiting the 
therapeutic window. In order to circumvent the side effects of animal antisera (anaphylaxis, serum 
sickness), recent research focused on humanized monoclonal antibodies or recombinant  
antibodies [325,326]. 
Apart from antibodies, different small molecules, glycostructures and aptamers have been 
approached and tested in vitro, but so far lacking convincing animal studies to show protection  
in vivo [267,313,327–330]. However, recently, small molecule inhibitors of intracellular retrograde 
ricin transport have been identified, one of which imparted protection to mice [331]. 
In order to protect selected persons at risk, e.g., military personnel and emergency service staff, 
there has been an interest in developing a vaccine against ricin intoxication. While there is no such 
vaccine readily available, one is in an advanced stage of legislative approval [332–335]: RiVaxTM is 
based on a recombinant catalytic inactive A-chain of ricin and was subjected to pilot clinical trials in 
humans where it was shown to induce functionally active antibodies. 
10. Conclusion 
Ricinus communis is of economic interest for the production of castor oil and the numerous 
industrial, medical and cosmetic products derived thereof. After detoxification, the defatted press cake 
of the oil production is industrially used as a by-product of organic fertilizer and as low-value feed. For 
a long time, intoxications of humans and animals with R. communis have been known, caused by the 
main toxic component of the plant, ricin. Among all plant poisonings reported, human cases of ricin 
poisoning are rare and the fatality rate is—based on modern supportive care—low (around 1.8% [165]), 
except for suicide cases where a ricin-containing extract is injected, reflecting the higher toxicity of 
ricin after parenteral application compared to oral uptake. Although cases of animal poisoning are less 
well surveyed, intoxications of animals, especially dogs, have been observed either by the unprocessed 
plant seeds or by processed castor cake products. Recent cases from Europe, Asia and America linked 
to R. communis-containing fertilizer show that the detoxification of castor cake is obviously 
problematic and not always thoroughly performed, calling for international regulations and stringent 
control to clearly limit the amount of ricin in fertilizer. This is even more important as the fatality rate 
in dogs—based on the limited number of cases available—seems to be higher than in humans (between 
7 and 35%; Table 2 and [224]). With respect to forensic analysis, ricin detection in clinical samples is 
difficult due to its rapid absorption and internalization within the tissue. As a surrogate marker, the 
alkaloid ricinine can be successfully monitored. 
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